Cartellieri, M
Feldmann, A
Koristka, S
Arndt, C
Loff, S
Ehninger, A
von Bonin, M
Bejestani, E P
Ehninger, G
Bachmann, M P
Article History
Received: 24 May 2016
Accepted: 27 May 2016
First Online: 12 August 2016
Competing interests
: MPB, AE and GE have filed patents and patent applications related to mAbs directed to CD33, La and the UniCAR platform technology. AE, SL and MC are employed by GEMoaB and CPT, respectively. The other authors declare no conflict of interest.